Evidence map›Paper›PMID 28208668›Full record

ReviewInternational journal of molecular sciences2017

Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.

Giona Sonego, Mélanie Abonnenc, Jean-Daniel Tissot, Michel Prudent, Niels Lion

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Redox Control in Platelet Activity and Therapy.Antioxidants (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. ROS in Platelet Biology: Functional Aspects and Methodological Insights.International journal of molecular sciences · 2020
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Giona SonegoTransfusion Interrégionale Croix Rouge Suisse SA, Laboratoire de Recherche sur les Produits Sanguins, Route de la Corniche 2, 1066 Epalinges, Switzerland. giona.sonego@itransfusion.ch.
Mélanie AbonnencTransfusion Interrégionale Croix Rouge Suisse SA, Laboratoire de Recherche sur les Produits Sanguins, Route de la Corniche 2, 1066 Epalinges, Switzerland. melanie.abonnenc@itransfusion.ch.
Jean-Daniel TissotTransfusion Interrégionale Croix Rouge Suisse SA, Laboratoire de Recherche sur les Produits Sanguins, Route de la Corniche 2, 1066 Epalinges, Switzerland. jean-daniel.tissot@itransfusion.ch.
Michel PrudentTransfusion Interrégionale Croix Rouge Suisse SA, Laboratoire de Recherche sur les Produits Sanguins, Route de la Corniche 2, 1066 Epalinges, Switzerland. michel.prudent@itransfusion.ch.
Niels LionTransfusion Interrégionale Croix Rouge Suisse SA, Laboratoire de Recherche sur les Produits Sanguins, Route de la Corniche 2, 1066 Epalinges, Switzerland. niels.lion@itransfusion.ch.
Service Régional Vaudois de Transfusion Sanguine · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentrates (PCs). The characteristics of PI-treated PCs slightly differ from those of untreated PCs, but the underlying reasons are not well understood. One possible cause is the generation of oxidative stress during the PI process. This is of great interest since reactive oxygen species (ROS) act as second messengers in platelet functions. Furthermore, there are links between protein oxidation and phosphorylation, another mechanism that is critical for cell regulation. Current research efforts focus on understanding the underlying mechanisms and identifying new target proteins. Proteomics technologies represent powerful tools for investigating signaling pathways involving ROS and post-translational modifications such as phosphorylation, while quantitative techniques enable the comparison of the platelet resting state versus the stimulated state. In particular, redox cysteine is a key player in platelet activation upon stimulation by different agonists. This review highlights the experiments that have provided insights into the roles of ROS in platelet function and the implications for platelet transfusion, and potentially in diseases such as inflammation and platelet hyperactivity. The review also describes the implication of redox mechanism in platelet storage considerations.

Indexed as

Oxidation-ReductionPlatelet ActivationProteomeProteomicsAnimalsAntioxidantsBlood PlateletsBlood PreservationCysteineHumansNADPH OxidasesOxidative StressPhosphorylationPlatelet AggregationPlatelet TransfusionReactive Oxygen SpeciesAntioxidantsCysteineNADPH OxidasesProteomeReactive Oxygen Speciesactivationaggregationblood productsphosphorylationplatelet functionplateletsreactive oxygen speciesredox cysteinetransfusion

Identifiers

PMID28208668
PMCPMC5343922
OpenAlexW2587799075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.